DNB Carnegie has published a new commissioned research report on Initiator Pharma.
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/initiator/
Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://www.carnegie.se/en/commissioned-research/, or contact our commissioned research team at cr@carnegie.se.
Contacts
Visiting address: Regeringsgatan 56, Stockholm
Site: http://www.carnegie.se
Telephone: +46 8-5886 88 00
About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.